Pharmacyte Biotech Inc. (PMCB)
NASDAQ · Healthcare
Pharmacyte Biotech Inc. Shareholder Equity 2011–2025
Pharmacyte Biotech Inc. annual/quarterly shareholder equity history from 2011 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Pharmacyte Biotech Inc. shareholder equity for the quarter ending April 30, 2025 were 51.9M, a 87.69% increase year-over-year.
- Pharmacyte Biotech Inc. shareholder equity for 2025 were 51.9M, a 87.69% increase from 2024.
- Pharmacyte Biotech Inc. shareholder equity for 2024 were 27.6M, a 61.97% decrease from 2023.
- Pharmacyte Biotech Inc. shareholder equity for 2023 were 72.7M, a 19.16% decrease from 2022.
- Pharmacyte Biotech Inc. shareholder equity for 2022 were 89.9M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Pharmacyte Biotech Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $52 |
| 2024 | $28 |
| 2023 | $73 |
| 2022 | $90 |
| 2021 | $7 |
| 2020 | $5 |
| 2019 | $5 |
| 2018 | $6 |
| 2017 | $8 |
| 2016 | $7 |
| 2015 | $8 |
| 2014 | $9 |
| 2013 | $-2 |
| 2012 | $-2 |
| 2011 | $-3 |
| Pharmacyte Biotech Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-04-30 | $52 |
| 2024-04-30 | $28 |
| 2023-04-30 | $73 |
| 2022-04-30 | $90 |
| 2021-04-30 | $7 |
| 2020-04-30 | $5 |
| 2019-04-30 | $5 |
| 2018-04-30 | $6 |
| 2017-04-30 | $8 |
| 2016-04-30 | $7 |
| 2015-04-30 | $8 |
| 2014-04-30 | $9 |
| 2013-04-30 | $-2 |
| 2012-04-30 | $-2 |
| 2011-04-30 | $-3 |
Pharmacyte Biotech Inc. Shareholder Equity — FAQ
Pharmacyte Biotech Inc. (PMCB) shareholder equity over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PMCB's shareholder equity history?
The chart and table above show Pharmacyte Biotech Inc.'s shareholder equity by year and by quarter, including the growth rate.